A citation-based method for searching scientific literature


List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.
Jennifer A Chan, Hongbing Zhang, Penelope S Roberts, Sergiusz Jozwiak, Grajkowska Wieslawa, Joanna Lewin-Kowalik, Katarzyna Kotulska, David J Kwiatkowski. J Neuropathol Exp Neurol 2004
184
50

Tuberous sclerosis complex-associated CNS abnormalities depend on hyperactivation of mTORC1 and Akt.
Paola Zordan, Manuela Cominelli, Federica Cascino, Elisa Tratta, Pietro L Poliani, Rossella Galli. J Clin Invest 2018
12
50

Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients.
Katarzyna Kotulska, Julita Borkowska, Marcin Roszkowski, Marek Mandera, Paweł Daszkiewicz, Krzysztof Drabik, Elzbieta Jurkiewicz, Magdalena Larysz-Brysz, Katarzyna Nowak, Wiesława Grajkowska,[...]. Pediatr Neurol 2014
36
50

Everolimus improves neuropsychiatric symptoms in a patient with tuberous sclerosis carrying a novel TSC2 mutation.
Su-Kyeong Hwang, Jae-Hyung Lee, Jung-Eun Yang, Chae-Seok Lim, Jin-A Lee, Yong-Seok Lee, Kyungmin Lee, Bong-Kiun Kaang. Mol Brain 2016
15
50


Elevated p62/SQSTM1 determines the fate of autophagy-deficient neural stem cells by increasing superoxide.
Chenran Wang, Song Chen, Syn Yeo, Gizem Karsli-Uzunbas, Eileen White, Noboru Mizushima, Herbert W Virgin, Jun-Lin Guan. J Cell Biol 2016
30
50

A novel human astrocyte cell line (A735) with astrocyte-specific neurotransmitter function.
T N Price, J F Burke, L V Mayne. In Vitro Cell Dev Biol Anim 1999
12
50

Heterogeneity of astrocytes: from development to injury - single cell gene expression.
Vendula Rusnakova, Pavel Honsa, David Dzamba, Anders Ståhlberg, Mikael Kubista, Miroslava Anderova. PLoS One 2013
70
50

Subependymal giant-cell tumor: astrocytic or neuronal?
Y Nakamura, L E Becker. Acta Neuropathol 1983
47
50

Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility.
Kyoichi Tomoto, Ayataka Fujimoto, Chikanori Inenaga, Tohru Okanishi, Shin Imai, Masaaki Ogai, Akiko Fukunaga, Hidenori Nakamura, Keishiro Sato, Akira Obana,[...]. BMC Neurol 2021
1
100

Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin.
Pike-See Cheah, Shilpa Prabhakar, David Yellen, Roberta L Beauchamp, Xuan Zhang, Shingo Kasamatsu, Roderick T Bronson, Elizabeth A Thiele, David J Kwiatkowski, Anat Stemmer-Rachamimov,[...]. Sci Adv 2021
1
100

Abnormal Neural Progenitor Cells Differentiated from Induced Pluripotent Stem Cells Partially Mimicked Development of TSC2 Neurological Abnormalities.
Yaqin Li, Jiqing Cao, Menglong Chen, Jing Li, Yiming Sun, Yu Zhang, Yuling Zhu, Liang Wang, Cheng Zhang. Stem Cell Reports 2017
31
50

Engineering adeno-associated virus vectors for gene therapy.
Chengwen Li, R Jude Samulski. Nat Rev Genet 2020
135
50

Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions.
Laura Magri, Marco Cambiaghi, Manuela Cominelli, Clara Alfaro-Cervello, Marco Cursi, Mauro Pala, Alessandro Bulfone, Jose Manuel Garcìa-Verdugo, Letizia Leocani, Fabio Minicucci,[...]. Cell Stem Cell 2011
155
50

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex.
David Neal Franz, Jennifer Leonard, Cynthia Tudor, Gail Chuck, Marguerite Care, Gopalan Sethuraman, Argirios Dinopoulos, George Thomas, Kerry R Crone. Ann Neurol 2006
413
50

Autophagic lipid metabolism sustains mTORC1 activity in TSC-deficient neural stem cells.
Chenran Wang, Michael A Haas, Fuchun Yang, Syn Yeo, Takako Okamoto, Song Chen, Jian Wen, Pranjal Sarma, David R Plas, Jun-Lin Guan. Nat Metab 2019
7
50

Genetically engineered human cortical spheroid models of tuberous sclerosis.
John D Blair, Dirk Hockemeyer, Helen S Bateup. Nat Med 2018
60
50

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.
David Neal Franz, Elena Belousova, Steven Sparagana, E Martina Bebin, Michael Frost, Rachel Kuperman, Olaf Witt, Michael H Kohrman, J Robert Flamini, Joyce Y Wu,[...]. Lancet 2013
468
50

Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.
Darcy A Krueger, Marguerite M Care, Katherine Holland, Karen Agricola, Cynthia Tudor, Prajakta Mangeshkar, Kimberly A Wilson, Anna Byars, Tarek Sahmoud, David Neal Franz. N Engl J Med 2010
631
50

Senescence and aging: the critical roles of p53.
A Rufini, P Tucci, I Celardo, G Melino. Oncogene 2013
372
50

Markers of cellular proliferation are expressed in cortical tubers.
Allana Lee, Michelle Maldonado, Marianna Baybis, Christopher A Walsh, Bernd Scheithauer, Raymond Yeung, Jack Parent, Howard L Weiner, Peter B Crino. Ann Neurol 2003
65
50

Tsc1 mutant neural stem/progenitor cells exhibit migration deficits and give rise to subependymal lesions in the lateral ventricle.
Jing Zhou, Gayatri Shrikhande, Jing Xu, Renée M McKay, Dennis K Burns, Jane E Johnson, Luis F Parada. Genes Dev 2011
74
50

Subependymal Giant Cell Astrocytoma (SEGA) Treatment Update.
Cynthia J Campen, Brenda E Porter. Curr Treat Options Neurol 2011
31
50

Immunohistochemical characterization of subependymal giant cell astrocytomas.
M B Lopes, H J Altermatt, B W Scheithauer, C W Shepherd, S R VandenBerg. Acta Neuropathol 1996
66
50

Everolimus for the treatment of refractory seizures associated with tuberous sclerosis complex (TSC): current perspectives.
Iris E Overwater, André B Rietman, Agnies M van Eeghen, Marie Claire Y de Wit. Ther Clin Risk Manag 2019
14
50

Traumatic scratch injury in astrocytes triggers calcium influx to activate the JNK/c-Jun/AP-1 pathway and switch on GFAP expression.
Kai Gao, Chen Ran Wang, Feng Jiang, Ann Yuen Kwan Wong, Na Su, Jiao Hua Jiang, Rui Chao Chai, Greg Vatcher, Junlin Teng, Jianguo Chen,[...]. Glia 2013
86
50

Tuberous sclerosis complex: a review.
Alexander K C Leung, W Lane M Robson. J Pediatr Health Care 2007
76
50

Mouse models of tuberous sclerosis complex.
Danielle K Scheidenhelm, David H Gutmann. J Child Neurol 2004
18
50

Subependymal giant cell astrocytomas with atypical histological features mimicking malignant gliomas.
Wiesława Grajkowska, Katarzyna Kotulska, Elżbieta Jurkiewicz, Marcin Roszkowski, Paweł Daszkiewicz, Sergiusz Jóźwiak, Ewa Matyja. Folia Neuropathol 2011
24
50

Molecular basis of giant cells in tuberous sclerosis complex.
David J Kwiatkowski, Brendan D Manning. N Engl J Med 2014
33
50

Cytogenetic changes in two cases of subependymal giant-cell astrocytoma.
M Debiec-Rychter, D Jesionek-Kupnicka, K Zakrzewski, P P Liberski. Cancer Genet Cytogenet 1999
12
50

Regulation of Integrin β 1 recycling to lipid rafts by Rab1a to promote cell migration.
Chenran Wang, Youngdong Yoo, Huaping Fan, Eunjung Kim, Kun-Liang Guan, Jun-Lin Guan. J Biol Chem 2010
66
50

FIP200 is required for maintenance and differentiation of postnatal neural stem cells.
Chenran Wang, Chun-Chi Liang, Z Christine Bian, Yuan Zhu, Jun-Lin Guan. Nat Neurosci 2013
100
50

Transcriptional regulation of the stress response by mTOR.
Jose Aramburu, M Carmen Ortells, Sonia Tejedor, Maria Buxadé, Cristina López-Rodríguez. Sci Signal 2014
52
50

mTORC1 Inhibition Corrects Neurodevelopmental and Synaptic Alterations in a Human Stem Cell Model of Tuberous Sclerosis.
Veronica Costa, Stefan Aigner, Mirko Vukcevic, Evelyn Sauter, Katharina Behr, Martin Ebeling, Tom Dunkley, Arno Friedlein, Sannah Zoffmann, Claas A Meyer,[...]. Cell Rep 2016
51
50

Oligodendrocytes as A New Therapeutic Target in Schizophrenia: From Histopathological Findings to Neuron-Oligodendrocyte Interaction.
Florian J Raabe, Lenka Slapakova, Moritz J Rossner, Ludovico Cantuti-Castelvetri, Mikael Simons, Peter G Falkai, Andrea Schmitt. Cells 2019
22
50

Cerebral organoids reveal early cortical maldevelopment in schizophrenia-computational anatomy and genomics, role of FGFR1.
E K Stachowiak, C A Benson, S T Narla, A Dimitri, L E Bayona Chuye, S Dhiman, K Harikrishnan, S Elahi, D Freedman, K J Brennand,[...]. Transl Psychiatry 2017
57
50

Reduced protein synthesis in schizophrenia patient-derived olfactory cells.
J A English, Y Fan, M Föcking, L M Lopez, M Hryniewiecka, K Wynne, P Dicker, N Matigian, G Cagney, A Mackay-Sim,[...]. Transl Psychiatry 2015
49
50

Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning.
Carl M Sellgren, Jessica Gracias, Bradley Watmuff, Jonathan D Biag, Jessica M Thanos, Paul B Whittredge, Ting Fu, Kathleen Worringer, Hannah E Brown, Jennifer Wang,[...]. Nat Neurosci 2019
163
50

Endogenous Cell Type-Specific Disrupted in Schizophrenia 1 Interactomes Reveal Protein Networks Associated With Neurodevelopmental Disorders.
Brent Wilkinson, Oleg V Evgrafov, DongQing Zheng, Nicolas Hartel, James A Knowles, Nicholas A Graham, Justin K Ichida, Marcelo P Coba. Biol Psychiatry 2019
12
50

GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression.
Grazyna Rajkowska, Gillian O'Dwyer, Zsofia Teleki, Craig A Stockmeier, Jose Javier Miguel-Hidalgo. Neuropsychopharmacology 2007
256
50

Modelling schizophrenia using human induced pluripotent stem cells.
Kristen J Brennand, Anthony Simone, Jessica Jou, Chelsea Gelboin-Burkhart, Ngoc Tran, Sarah Sangar, Yan Li, Yangling Mu, Gong Chen, Diana Yu,[...]. Nature 2011
860
50

Δ9-tetrahydrocannabinol and 2-AG decreases neurite outgrowth and differentially affects ERK1/2 and Akt signaling in hiPSC-derived cortical neurons.
Carole Shum, Lucia Dutan, Emily Annuario, Katherine Warre-Cornish, Samuel E Taylor, Ruth D Taylor, Laura C Andreae, Noel J Buckley, Jack Price, Sagnik Bhattacharyya,[...]. Mol Cell Neurosci 2020
8
50

Correspondence of DNA Methylation Between Blood and Brain Tissue and Its Application to Schizophrenia Research.
Esther Walton, Johanna Hass, Jingyu Liu, Joshua L Roffman, Fabio Bernardoni, Veit Roessner, Matthias Kirsch, Gabriele Schackert, Vince Calhoun, Stefan Ehrlich. Schizophr Bull 2016
140
50

On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D2/3 receptor agonist radioligand study.
Ana Weidenauer, Martin Bauer, Ulrich Sauerzopf, Lucie Bartova, Lukas Nics, Sarah Pfaff, Cecile Philippe, Neydher Berroterán-Infante, Verena Pichler, Bernhard M Meyer,[...]. Transl Psychiatry 2020
10
50

Using Cell Cultures for the Investigation of Treatments for Attention Deficit Hyperactivity Disorder: A Systematic Review.
Danielly Chierrito, Camila B Villas-Boas, Fernanda S Tonin, Fernando Fernandez-Llimos, Andréia C C Sanches, João C P de Mello. Curr Neuropharmacol 2019
1
100

Transcriptomic Landscape and Functional Characterization of Induced Pluripotent Stem Cell-Derived Cerebral Organoids in Schizophrenia.
Annie Kathuria, Kara Lopez-Lengowski, Smita S Jagtap, Donna McPhie, Roy H Perlis, Bruce M Cohen, Rakesh Karmacharya. JAMA Psychiatry 2020
16
50

Pathological priming causes developmental gene network heterochronicity in autistic subject-derived neurons.
Simon T Schafer, Apua C M Paquola, Shani Stern, David Gosselin, Manching Ku, Monique Pena, Thomas J M Kuret, Marvin Liyanage, Abed AlFatah Mansour, Baptiste N Jaeger,[...]. Nat Neurosci 2019
91
50

Next-generation disease modeling with direct conversion: a new path to old neurons.
Larissa Traxler, Frank Edenhofer, Jerome Mertens. FEBS Lett 2019
17
50

Activated microglia cause metabolic disruptions in developmental cortical interneurons that persist in interneurons from individuals with schizophrenia.
Gun-Hoo Park, Haneul Noh, Zhicheng Shao, Peiyan Ni, Yiren Qin, Dongxin Liu, Cameron P Beaudreault, Joy S Park, Chiderah P Abani, James M Park,[...]. Nat Neurosci 2020
2
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.